Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:45 PM
Ignite Modification Date:
2025-12-24 @ 7:45 PM
NCT ID:
NCT05043103
Eligibility Criteria:
Inclusion Criteria:
* Adult Patients (18 years old and over) with Advanced Parkinson Disease already under treatment with Lecigon® (for up to 3 months before giving informed consent) in accordance with the Summary of Product Characteristics (SmPC)
* Patients or legal representative must have signed informed consent to participate in the study
* Patients are not taking part in another clinical (interventional) study at the same time
Exclusion Criteria:
* Patients with contraindications as defined in the current version of the SmPC for Lecigon®
* Patients who will not be seen again for their follow up care at the investigator's site after commencement of Lecigon® therapy
* Patients with pump placement or pump use issues, e.g. patients with acute severe illness, patients unable to perform pump therapy, and in case of lacking compliance due to severe dementia, agitation or alcohol abuse
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05043103
Study Brief:
Protocol Section:
NCT05043103